The Food and Drug Administration (FDA) has approved the emergency use of the AstraZeneca Covid-19 vaccine and 50,000 doses will arrive in Thailand in February.
FDA secretary-general Paisarn Dunkum said the FDA approved the registration of the vaccine, produced in Italy by AstraZeneca Co, on Wednesday after the firm had submitted over 9,000 pages of documents.